Select Publications

Book Chapters

Madden A; Lennon P; Hogan C; Getty M; Hopwood M; Neale J; Treloar C, 2019, 'Patient-reported measures as a justice project through involvement of service-user researchers', in Aggleton P; Broom A; Moss J (ed.), Practical Justice: Principles, Practice and Social Change, Routledge, pp. 190 - 199, http://dx.doi.org/10.4324/9781351010498

Treloar C, 2014, 'Applying Principles of Mindlessness-Mindfulness Theory and Drug-Injecting Behavior', in The Wiley Blackwell Handbook of Mindfulness, pp. 818 - 833, http://dx.doi.org/10.1002/9781118294895.ch41

Hopwood MN; Treloar C, 2013, 'International Policies to Reduce Illicit Drug-Related Harm and Illicit Drug Use', in Interventions for addiction: Comprehensive addictive behaviors and disorders, Elsevier Science Publishing Co Inc, San Diego, USA, pp. 735 - 743, http://dx.doi.org/10.1016/B978-0-12-398338-1.00075-0

Loveday S; Treloar C; Elek C; Hopwood MN, 2005, 'Discrimination to the consumer', in Australian Society for HIV Medicine (ed.), HIV and viral hepatitis: Legal, ethical and human rights issues, edn. Original, Australian Society for HIV Medicine, Sydney, pp. 43 - 56

Journal articles

Marshall AD; Hopwood M; Grebely J; Treloar C, 2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, vol. 86, http://dx.doi.org/10.1016/j.drugpo.2020.102964

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2020, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.', Addiction, http://dx.doi.org/10.1111/add.15277

Broady TR; Brener L; Hopwood M; Cama E; Treloar C; Holt M, 2020, 'HIV stigma by association among Australian gay and bisexual men.', AIDS, vol. 34 Suppl 1, pp. S53 - S62, http://dx.doi.org/10.1097/QAD.0000000000002565

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, vol. 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

Brener L; Broady T; Cama E; Hopwood M; de Wit JBF; Treloar C, 2020, 'The role of social support in moderating the relationship between HIV centrality, internalised stigma and psychological distress for people living with HIV', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 32, pp. 850 - 857, http://dx.doi.org/10.1080/09540121.2019.1659914

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, vol. 9, pp. e15113, http://dx.doi.org/10.2196/15113

Drysdale K; Bryant J; Holt M; Hopwood M; Dowsett GW; Aggleton P; Lea T; Treloar C, 2020, 'Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use', International Journal of Drug Policy, vol. 78, pp. 102697, http://dx.doi.org/10.1016/j.drugpo.2020.102697

Broady TR; Brener L; Cama E; Hopwood M; Treloar C, 2020, 'Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population', PLoS ONE, vol. 15, pp. e0232218, http://dx.doi.org/10.1371/journal.pone.0232218

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, vol. 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, vol. 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, vol. 77, pp. 102693 - 102693, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Hopwood M; Cama E; de Wit J; Treloar C, 2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, vol. 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536

Gray R; Kelly PJ; Beck AK; Baker AL; Deane FP; Neale J; Treloar C; Hides L; Manning V; Shakeshaft A; Kelly J; Argent A; McGlaughlin R, 2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, vol. 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144

Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy, vol. 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170

Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, vol. 206, pp. 107705, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705

Stoové M; Wallace J; Higgs P; Pedrana A; Goutzamanis S; Latham N; Scott N; Treloar C; Crawford S; Doyle J; Hellard M, 2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, vol. 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, vol. 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, vol. 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C, 2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, vol. 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016

Bryant J; Rance J; Hull P; Mao L; Treloar C, 2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, vol. 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002

Walker M; Beadman K; Griffin S; Beadman M; Treloar C, 2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, vol. 16, pp. 52, http://dx.doi.org/10.1186/s12954-019-0325-3

Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, vol. 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112

Rhodes T; Lancaster K; Harris M; Treloar C, 2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, vol. 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475

Brener L; Cama E; Broady T; Hopwood M; de Wit J; Treloar C, 2019, 'Predictors of health care workers’ support for discriminatory treatment and care of people who inject drugs', Psychology, Health and Medicine, vol. 24, pp. 439 - 445, http://dx.doi.org/10.1080/13548506.2018.1546018

Madden A; Hopwood M; Neale J; Treloar C, 2019, 'Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs', Patient, vol. 12, pp. 259 - 265, http://dx.doi.org/10.1007/s40271-018-0332-6

Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J, 2019, 'Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs', International Journal of Drug Policy, vol. 66, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.01.012

Treloar C; Pienaar K; Dilkes-Frayne E; Fraser S, 2019, 'Lives of Substance: a mixed-method evaluation of a public information website on addiction experiences', Drugs: Education, Prevention and Policy, vol. 26, pp. 140 - 147, http://dx.doi.org/10.1080/09687637.2017.1397602

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Clark Y; Quinn B; Treloar C; Gray D; Dunlop A; Roe Y; Ward J, 2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, vol. 21, http://dx.doi.org/10.2196/14084

Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, vol. 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013

Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J, 2019, 'Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework', Liver International, vol. 39, pp. 20 - 30, http://dx.doi.org/10.1111/liv.13949

Broady TR; Cama E; Brener L; Hopwood M; de Wit J; Treloar C, 2018, 'Responding to a national policy need: development of a stigma indicator for bloodborne viruses and sexually transmissible infections', Australian and New Zealand Journal of Public Health, vol. 42, pp. 513 - 515, http://dx.doi.org/10.1111/1753-6405.12809

Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, vol. 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987

Levy M; Treloar C, 2018, 'Health protection and Australian prisons, 2018', The Medical Journal of Australia, vol. 209, pp. 460 - 461, http://dx.doi.org/10.5694/mja18.00669

Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, vol. 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011

Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?', PLoS ONE, vol. 13, pp. e0207226, http://dx.doi.org/10.1371/journal.pone.0207226

Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, vol. 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141

Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond cure: Patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia', Harm Reduction Journal, vol. 15, http://dx.doi.org/10.1186/s12954-018-0248-4

Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, vol. 15, http://dx.doi.org/10.1186/s12954-018-0246-6

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Building on feminist achievements to enhance choice for women seeking treatment', Addiction, vol. 113, pp. 1001 - 1002, http://dx.doi.org/10.1111/add.14226

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Do women with complex alcohol and other drug use histories want women-only residential treatment?', Addiction, vol. 113, pp. 989 - 997, http://dx.doi.org/10.1111/add.14131

Treloar C; Hopwood M; Cama E; Saunders V; Jackson LC; Walker M; Ooi C; Ubrihien A; Ward J, 2018, 'Evaluation of the Deadly Liver Mob program: Insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care', Harm Reduction Journal, vol. 15, http://dx.doi.org/10.1186/s12954-018-0209-y

Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, vol. 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030

Fraser S; Treloar C; Gendera S; Rance J, 2017, '‘Affording’ new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention', International Journal of Drug Policy, vol. 50, pp. 19 - 35, http://dx.doi.org/10.1016/j.drugpo.2017.07.001

Marshall AD; Grebely J; Dore GJ; Treloar C, 2017, '‘I didn't want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study', International Journal of Drug Policy, vol. 47, pp. 153 - 160, http://dx.doi.org/10.1016/j.drugpo.2017.06.001

Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, vol. 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562

Pienaar K; Moore D; Fraser S; Kokanovic R; Treloar C; Dilkes-Frayne E, 2017, 'Diffracting addicting binaries: An analysis of personal accounts of alcohol and other drug ‘addiction’', Health (United Kingdom), vol. 21, pp. 519 - 537, http://dx.doi.org/10.1177/1363459316674062


Back to profile page